Venlafaxine (Effexor) and duloxetine (Cymbalta) are two of the newest antidepressants to be approved for use in the treatment of depression.These drugs were developed because of their ability to
A) more selectively inhibit monoamine oxidase
B) more selectively enhance monoamine reuptake
C) selectively inhibit the reuptake of both serotonin and norepinephrine
D) selectively inhibit the reuptake of dopamine
Correct Answer:
Verified
Q48: The most significant problem associated with the
Q49: The so-called "serotonin syndrome" is most likely
Q50: The use of tricyclic antidepressants for the
Q51: The primary benefits of the newer antidepressants
Q52: Which of the following phenomena is supportive
Q53: Which of the following pharmacodynamic properties do
Q54: Which of the following is NOT one
Q56: Of the antidepressants in clinical use today,
Q57: Although effective in the treatment of depression,
Q58: When would it be most appropriate to
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents